Clinical trial sponsors expanding studies across Europe often face complex regulatory pathways for sample testing, ...

AI in clinical trials holds great promise for the entire drug development lifecycle. However, any new technology should ...

Wearable sensors remain largely underused, despite their utility in improving data collection and regulatory compliance.

A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...

Industry groups have asked the US Food and Drug Administration (FDA) to provide more clarity about its regulatory approach to ...

Scott Piergrossi, president of creative for the healthcare industry naming giant Brand Institute, estimated that acronyms only make up about one-third of the trial names the institute helps create.

AMT-260 was generally well-tolerated with no serious adverse events observed to date, with early biological signals of potential therapeutic ...

GLP-1s do not harm male hormones or fertility after long-term use, according to a study being presented Monday at ENDO 2026, ...